Nimbus Therapeutics vs Vividion Therapeutics
Nimbus Therapeutics vs Vividion Therapeutics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Nimbus Therapeutics is on 51/100 and Vividion Therapeutics on 22/100.
Where each one leads
Nimbus Therapeutics
- our overall score: 51/100 against 22/100
- domain rating: 55/100 against 37/100
- funding raised: $589M against $267M
Vividion Therapeutics
- agent readiness: 42/100 against 27/100
At a glance
| Measure | Nimbus Therapeutics | Vividion Therapeutics |
|---|---|---|
| What it is | Nimbus Therapeutics is a clinical-stage biotech company using computational drug discovery to develop small molecule medicines. | Biopharmaceutical company developing novel therapeutics for cancer and other diseases using chemoproteomics and covalent chemistry. |
| Category | Biotechnology, Drug Discovery, AI, Machine Learning | Biotech, Drug Discovery, Oncology, Therapeutics |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Biotech |
| Founded | 2009 | 2017 |
| Headquarters | Boston, United States | San Diego, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Nimbus Therapeutics | Vividion Therapeutics |
|---|---|---|
| Employees | Not published | 265 |
| Total funding | $589M | $267M |
| Latest round | Series F | Series C |
| LinkedIn followers | Not published | 18,737 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Nimbus Therapeutics | Vividion Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 51/100 | 22/100 |
| Traction | 40/100 | 40/100 |
| Team | 30/100 | 30/100 |
| Community | 8/100 | 15/100 |
| Search visibility | 18/100 | Not published |
| Quality | 70/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (27/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 55/100 | 37/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Nimbus Therapeutics | Vividion Therapeutics |
|---|---|---|
| Hosting | Google Cloud | Google Cloud |
| CMS | WordPress | WordPress |
| Frameworks | Not detected | Jquery, Bootstrap |
| Analytics | Google Analytics 4, Segment, Microsoft Clarity | Google Analytics 4 |
Nimbus Therapeutics vs Vividion Therapeutics: common questions
Which is better, Nimbus Therapeutics or Vividion Therapeutics?
On our 0-100 score Nimbus Therapeutics rates higher (51/100 against 22/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Nimbus Therapeutics and Vividion Therapeutics compare on the numbers?
Nimbus Therapeutics leads on our overall score (51/100 against 22/100), domain rating (55/100 against 37/100), funding raised ($589M against $267M). Vividion Therapeutics leads on agent readiness (42/100 against 27/100).
Read the full Nimbus Therapeutics review and pricing or the Vividion Therapeutics review and pricing. You can also browse other Nimbus Therapeutics alternatives we track.